Teng C S, Yeo P P
Br Med J. 1977 Jan 29;1(6056):273-5. doi: 10.1136/bmj.1.6056.273.
Of 27 patients with ophthalmic Graves's disease (OGD) who had been clinically euthyroid three years previously, one became clinically hyperthyroid and seven overtly hypothyroid. Improvement in eye signs was associated with a return to normal of thyroidal suppression by triiodothyronine (T3) and of the response of thyroid-stimulating hormone (TSH) to thyrotrophin-releasing hormone (TRH). Of a further 30 patients with OGD who had not been studied previously, three were overtly hypothyroid. Of the combined series, 46 patients were euthyroid, 18 (40%) of whom had an impaired or absent TSH response to TRH, and 3(6-7%) an exaggerated response. Eleven out of 37 patients (29-7%) had abnormal results in the T3 suppression test. There was a significant correlation between thyroidal suppression by T3 and the TSH response to TRH. Total serum concentrations of both T3 and thyroxine (T4) were closely correlated with T3 suppressibility and TRH responsiveness. Free T4 and T3 (fT3) concentrations were normal in all but three patients, in whom raised fT3 was accompanied by abnormal TSH responses and thyroidal suppression. The presence of normal free thyroid hormone concentrations in patients with impaired or absent TSH responses to TRH is interesting and challenges the concept that free thyroid hormones are the major controlling factors in the feedback control of TSH.
在27例三年前临床甲状腺功能正常的Graves眼病(OGD)患者中,1例临床转为甲状腺功能亢进,7例转为明显的甲状腺功能减退。眼部体征的改善与三碘甲状腺原氨酸(T3)对甲状腺的抑制作用以及促甲状腺激素(TSH)对促甲状腺激素释放激素(TRH)的反应恢复正常有关。在另外30例之前未被研究过的OGD患者中,3例为明显的甲状腺功能减退。在整个系列中,46例患者甲状腺功能正常,其中18例(40%)对TRH的TSH反应受损或缺失,3例(6 - 7%)反应过度。37例患者中有11例(29 - 7%)T3抑制试验结果异常。T3对甲状腺的抑制作用与TSH对TRH的反应之间存在显著相关性。血清总T3和甲状腺素(T4)浓度与T3抑制性和TRH反应性密切相关。除3例患者外,所有患者的游离T4和T3(fT3)浓度均正常,这3例患者fT3升高伴有TSH反应异常和甲状腺抑制。TSH对TRH反应受损或缺失的患者中游离甲状腺激素浓度正常,这一现象很有趣,对游离甲状腺激素是TSH反馈控制的主要控制因素这一概念提出了挑战。